Krka Group’s EBITDA margin is to plummet by more than nine percentage points as reported for the first half of 2022, from 31.5% to 22.4%, as a result of the Slovenian firm increasing inventories of raw materials, materials, bulk products, and products required for “long-term uninterrupted supply of Krka’s pharmaceuticals in the Russian market.”
Announcing the Krka group’s unaudited business results and main operating estimates for the first half of this year, Krka has...







